[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4419 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 4419
To amend the Public Health Service Act with respect to the Public
Health Emergency Medical Countermeasures Enterprise, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 30, 2023
Mr. Hudson introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act with respect to the Public
Health Emergency Medical Countermeasures Enterprise, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``PHEMCE Advisory Committee Act of
2023''.
SEC. 2. PUBLIC HEALTH EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE.
(a) Members.--Section 2811-1(b) of the Public Health Service Act
(42 U.S.C. 30hh-10a(b)) is amended by striking paragraph (11) and
inserting the following:
``(11) The Director of the Biomedical Advanced Research and
Development Authority.
``(12) The Director of the Strategic National Stockpile.
``(13) Representatives of any other Federal agency, which
may include the Director of the National Institute of Allergy
and Infectious Diseases and the Director of the Office of
Public Health Preparedness and Response, as the Secretary
determines appropriate.''.
(b) Functions.--Section 2811-1(c)(2) of the Public Health Service
Act (42 U.S.C. 30hh-10a(c)(2)) is amended to read as follows:
``(2) Input.--In carrying out this section, the PHEMCE
shall solicit and consider input from--
``(A) the PHEMCE Advisory Committee maintained
under subsection (d), as appropriate; and
``(B) State, local, Tribal, and territorial public
health departments or officials, as appropriate.''.
(c) Advisory Committee.--Section 2811-1 of the Public Health
Service Act (42 U.S.C. 30hh-10a) is amended by adding at the end the
following:
``(d) PHEMCE Advisory Committee.--
``(1) Establishment.--The Secretary shall--
``(A) establish and maintain an advisory committee
to be known as the PHEMCE Advisory Committee (in this
subsection referred to as the `Advisory Committee') to
seek input and ensure communication and transparency in
the functions of the PHEMCE; and
``(B) seek input from and consult with external
partners with divergent threat portfolios, including
chemical, biological, radiological, or nuclear agents
and emerging infectious diseases, to ensure the right
combination of threat-specific expertise on PHEMCE
functions under subsection (c)(1) and to ensure
appropriate capability and capacity to maintain overall
readiness.
``(2) Duties.--The Advisory Committee shall--
``(A) provide advice to the PHEMCE in carrying out
its functions;
``(B) solicit and incorporate the input of the
private sector, non-Federal partners, and stakeholders
to increase communication and transparency, identify
gaps of preparedness, and coordinate improvements in
PHEMCE decision-making;
``(C) aid in the PHEMCE's strategic planning and
decision-making regarding medical countermeasure
research, advanced research, development, procurement,
stockpiling, replenishment, deployment, and
distribution;
``(D) aid in interactions among the PHEMCE's
members listed in subsection (b) and other government
entities; and
``(E) aid in the PHEMCE's communication of
decisions related to the PHEMCE's functions.
``(3) Membership.--The Secretary, in consultation with the
members of the PHEMCE listed in subsection (b), shall appoint
to the Advisory Committee at least 9, and not more than 11,
individuals, including--
``(A) at least 3 non-Federal professionals with
expertise in medical countermeasure development,
including medical countermeasures for chemical,
biological, radiological, or nuclear agents and
emerging infectious diseases;
``(B) at least 2 non-Federal professionals with
expertise in medical countermeasure stockpiling and
replenishment;
``(C) at least 2 non-Federal professionals with
expertise in the medical countermeasure supply chain,
including medical countermeasure manufacturing and
distribution;
``(D) at least 2 non-Federal professionals with
expertise in medical disaster planning, preparedness,
response, or recovery;
``(E) 1 non-Federal professional appointed by the
Speaker of the House of Representatives;
``(F) 1 non-Federal professional appointed by the
minority leader of the House of Representatives;
``(G) 1 non-Federal professional appointed by the
majority leader of the Senate; and
``(H) 1 non-Federal professional appointed by the
minority leader of the Senate.
``(4) Term of appointment.--Each member of the Advisory
Committee shall be appointed for a term of 2 years and may be
reappointed for two additional terms of 2 years, for a total of
not more than 6 years. The first and second such terms may be
consecutive. The third such term may not be consecutive.
``(5) Meetings.--The Advisory Committee shall--
``(A) meet not less than 4 times in each calendar
year that begins after the establishment of the
Advisory Committee;
``(B) hold all meetings in-person;
``(C) for purposes of ensuring transparency,
provide adequate advance notice of the date of each
meeting, including by publicly posting the meeting date
30 days before the date on which the meeting is to be
held;
``(D) not later than 60 days after each meeting,
communicate the activities carried out and decisions
made during, and minutes of, such meeting to the
appropriate congressional committees; and
``(E) not later than 30 days after each meeting,
communicate the activities carried out and decisions
made during, and minutes of, such meeting to the
PHEMCE.''.
<all>